The 6-minute walk test (6MWT) is often used to assess walking distance in multiple sclerosis (MS), but can be both time consuming for the investigator and exhausting for people with MS (pwMS). The present report compared the 6MWT scores of 40 ambulatory pwMS with their scores on the shorter 2-minute walk test (2MWT). The 2MWT estimated the 6MWT results with a mean relative error of 5% (R 2 ¼ 0.96; p < 0.01). As the last 4-minute period of the 6MWT seems redundant, the 2MWT may be considered as a practical replacement for the 6MWT in routine clinical assessment.
Introduction
Examination of functional mobility in clinical practice frequently includes an assessment of the distance a person can walk during a given time period. The 6MWT is a commonly used measure of walking distance across different study populations, 1-3 with normative values available for comparison. 1 In MS, the 6MWT was found to be a feasible, reliable and responsive measure. 4, 5 Although test results were shown to correlate strongly with community ambulation, 6 clinicians may be reluctant to implement this walking capacity test. The time it takes for the 6MWT and the burden to pwMS, especially in those with increased disability, are important concerns.
The 2MWT may be a pragmatic alternative for the 'gold standard' 6MWT. This shorter test has been validated in subjects with respiratory disease and stroke, 7, 8 and has been used as an outcome measure in MS rehabilitation trials. 9 However, it is still unclear if the 2MWT and 6MWT provide similar clinical information in pwMS.
The objective of this study was to compare performances on the 2MWT and 6MWT in a sample of ambulatory pwMS. It was hypothesized that both measures capture the same aspects of mobility.
Methods
A convenience sample was recruited among pwMS scheduled at the REVAL Rehabilitation Research Centre and the Rehabilitation and MS Centre, Overpelt, Belgium. Included subjects (n ¼ 40) had a definite diagnosis of MS according to the McDonald criteria and preservation of at least some ambulatory function (Expanded Disability Status Scale [EDSS] 1.5-6.5, median score 3.5; age 48 AE 10 years; disease duration 11 AE 7 years); of these, 8 required a walking aid (i.e. a cane, crutch(es) or rollator). Subjects had not experienced an exacerbation in the month prior to testing, and had no other medical conditions that interfered with walking. All subjects consented to participate in a cross-sectional research protocol that was approved by the appropriate ethical committees.
Administration of the 2MWT and 6MWT occurred in random order, as decided by a pre-ordered sealed envelope, and was separated by a 30-minute rest period. Walk tests were administered by the same investigator, adopting the instruction script of Goldman et al. 4 Subjects walked, at maximal effort, back and forth in a 30-meter hallway turning round cones, and were permitted to use their habitual assistive devices. Distances walked per minute and total distance were registered. Subjects also completed the 12-item MS Walking Scale (MSWS-12; range 0-100) and the 9-item physical subindex of the Modified Fatigue Impact Scale (MFIS; range 0-36), respectively questioning self-perceived walking ability and physical fatigue.
Data were checked for normality through means of the Shapiro-Wilk statistic. A repeated measures analysis of variance was applied to compare the walking distances under the 2MWT and the first 2 minutes of the 6MWT (2 0 _6MWT). A one-way analysis of variance helped examine whether the subjects' walking pace differed during 1-minute intervals of the 6MWT. A univariate regression analysis was used to assess the association between the 2MWT and the 6MWT. The obtained regression equation was implemented to plot the estimated 6MWT versus the actual 6MWT results, in terms of absolute error as well as relative error (i.e. 100*absolute error/actual 6MWT result). Additionally, Spearman rank correlations were computed to determine the relationship between the walk tests and the EDSS, MSWS-12 and MFIS physical subindex. All analyses were performed using Statistica (Statsoft Inc, Tulsa, USA), with level of significance set at p < 0.05.
Results
All data were distributed normally. Total distances walked under the 2MWT and 6MWT were 149 AE 48 (range 30-223) and 421 AE 145 m (70-666) respectively.
Walking distances across 1-minute intervals of the 2MWT and 2 0 _6MWT did not differ significantly (p ¼ 0.82). Both the 2MWT and 2 0 _6MWT showed the same, albeit non-significant decrease in mean distance over time (i.e. 3 m; see Figure 1 ). Furthermore, walking distances across 1-minute intervals of the 6MWT did not differ significantly (p ¼ 0.94), and were constant during the last 4-minute period (mean Pearson correlation coefficient r ¼ 0.99; see Figure 1 ).
The 2MWT results explained 96% of the distance covered in the 6MWT (R 2 ¼ 0.96; p < 0.01). The regression equation (6MWT ¼ 2.95*2MWT -19.19) enabled the estimation of the actual 6MWT results with a mean absolute error of 21 AE 12 m (1-44), corresponding to a relative error of 5 AE 4% (0-10); this is illustrated in Figure 2 .
On average, subjects rated themselves 53 AE 21 (19-90) on the MSWS-12 and 20 AE 6 (11-30) on the MFIS physical subindex. The 2MWT and 6MWT, respectively, produced equivalent correlations with the EDSS (r ¼ À0.61; r ¼ À0.65), MSWS-12 (r ¼ À0.72; r ¼ À0.67), and MFIS physical subindex (r ¼ À0.31; r ¼ À0.29).
Discussion
This report is one of few studies that validates the use of the shorter 2MWT as a measure of walking distance. 7, 8 The strong association between the 2MWT and 6MWT provides evidence that these two walk tests capture the same aspects of mobility in ambulatory pwMS. Based on individual 2MWT scores, true performance on the 6MWT could be adequately estimated in all subjects. Largest absolute errors were seen in pwMS with mild ambulatory dysfunction, those with a distance greater than 450 m (see Figure 2) ; but estimation errors were overall comparable between subjects with diverse ambulation status. Contrasted with the 6MWT's minimal detectable change and minimally important change of respectively 92 and 55 m in pwMS (EDSS 0-6.5), 5 the current mean absolute error of 21 m may be regarded as fairly low.
In accordance with the findings of Butland et al. 7 after an initial 'burst' during the 2 0 _6MWT, subjects tented to pace themselves consistently during the last 4 minutes of the 6MWT. In present report, the 2MWT and 6MWT related equally well to overall disability and physical fatigue, and both previously have proven to be good estimators of the habitual walking performance recorded through accelerometry. 6 In respiratory disease, the two walk tests have already demonstrated similar levels of responsiveness. 10 When interpreting the results, one should keep in mind that the subjects represent a limited, conveniently recruited sample of pwMS.
In summary, the evidence supports the 2MWT as practical replacement for the 6MWT in routine clinical assessment (decreasing time and burden in the life-long management of pwMS). Follow-up research is now warranted to determine and compare the 2MWT and 6MWT's sensitivity to change subsequent to intervention. 
